FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy 
Qantas Raises International Fares as Middle East Conflict Drives Jet Fuel Costs Higher 
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 
NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay 
Nintendo Stock Surges 10% as Pokémon Pokopia Breaks Sales Records 
Alphabet's GFiber Merges with Astound Broadband to Build Major U.S. Internet Provider 
BMW Warns of Further Earnings Decline in 2026 Amid Global Trade Pressures 
Estée Lauder Sues Jo Malone Over Trademark Dispute Involving Zara 
Nvidia CEO Jensen Huang Says $100B OpenAI Investment Unlikely as AI Demand Surges 
Trump Signs Executive Order to Boost AI Research in Childhood Cancer 
Trump Administration Proposes Tough AI Contract Rules as Anthropic Blacklisted by Pentagon 
Jared Isaacman Confirmed as NASA Administrator, Becomes 15th Leader of U.S. Space Agency 
Oracle Stock Surges as AI Data Center Boom Drives Revenue Beat and Bullish 2027 Outlook 
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug 
Microsoft Backs Anthropic in Legal Fight Against Pentagon's AI Blacklist 
Pokemon Pokopia Sells 2.2 Million Copies in Four Days, Boosting Nintendo Switch 2 Momentum 
Elon Musk’s brain-computer interface company Neuralink is preparing for a major expansion, announcing plans to begin high-volume production of its brain implant devices and transition to a fully automated surgical procedure by 2026. The announcement was made by Musk in a post on the social media platform X, highlighting the company’s long-term vision to scale its neurotechnology and make implantation faster, safer, and more accessible.
Neuralink’s brain implant technology is designed to help people with severe neurological conditions, including spinal cord injuries and paralysis, by enabling direct communication between the brain and external devices. The implant allows users to control digital tools using their thoughts, opening new possibilities for restoring independence and improving quality of life. According to previously shared updates, the first patient implanted with the device has successfully used it to play video games, browse the internet, post on social media, and control a laptop cursor without physical movement.
The company began human trials of its brain-computer interface in 2024 after resolving safety concerns raised by the U.S. Food and Drug Administration. The FDA had initially rejected Neuralink’s application in 2022, citing potential risks, but later approved the trials after additional safeguards were implemented. This marked a significant milestone for the company and the broader neurotechnology industry.
In September, Neuralink revealed that 12 people worldwide with severe paralysis had already received its brain implants. These individuals were reportedly using the technology to control both digital and physical tools purely through thought, demonstrating the real-world potential of brain-computer interfaces. The company has also attracted strong investor interest, securing $650 million in a funding round completed in June, further supporting its research, development, and manufacturing goals.
While Neuralink did not immediately respond to a request for comment, Musk’s statement suggests the company is moving toward large-scale deployment. If successful, high-volume production and fully automated surgical implantation could significantly accelerate adoption of brain implant technology, positioning Neuralink as a leader in the rapidly evolving field of neural interfaces and medical innovation.
